1️⃣ Series A

Ochre Bio

1️⃣ Series A

Biotech

Medical Device

Health Tech

Ochre Bio develops RNA-based therapies for under-treated chronic liver diseases. Its discovery platform combines machine learning, genomic phenotyping, RNA chemistry, and perfused human-donor livers—enabling rapid identification of novel therapeutic targets.

Similar startups

Genie Fertility

Genie Fertility’s tests sample endometrial tissue painlessly to assess implantation potential. Clinics use these insights to tailor IVF protocols, improve success rates, and lower overall treatment costs.

NeuroSonic

NeuroSonic enables clinicians to instantly assess blood flow in arteries supplying the brain, a crucial indicator of stroke risk. Its personalized insights empower care teams to detect risk factors earlier and tailor interventions.

FabricNano

FabricNano engineers bespoke enzymes to catalyze industrial processes under mild conditions. Their microfluidic screening and protein design accelerate biocatalyst discovery—reducing waste and energy use in chemical and pharmaceutical production.

Inoviv

Inoviv delivers custom, multiplexed LC-MS proteomics panels with absolute quantification and end-to-end support for biomarker discovery and validation. These workflows yield high reproducibility and accuracy—helping pharmaceutical teams accelerate development and reduce risk in clinical programs.

Micrographia Bio

Micrographia Bio combines imaging mass spectrometry and AI to map protein distributions in tissues. Its platform uncovers drug targets and mechanism insights at cellular resolution—accelerating therapeutic development.

Better Dairy

Better Dairy uses precision fermentation to produce bioidentical whey and casein without livestock. Its animal-free proteins offer the taste and functionality of dairy—enabling brands to sustainably create cheeses, yogurts, and more.